Clinical Trials Arena on MSN
FDA finalises psychedelic clinical trial guidance
The FDA is holding a public hearing to talk through psychedelic drug development on 14 September.
The Trump administration has released its latest unified agenda, laying out the proposed and final rules its agencies plan to ...
The US Food and Drug Administration's finalized guidance on psychedelic drug development signals the agency remains receptive ...
Would you want two strangers in the room with you for hours while you're on mushrooms? The federal government just decided ...
The FDA's draft guidance could streamline biosimilar approval by reducing the need for comparative efficacy studies, emphasizing analytical assessments instead. This approach may lower development ...
The head of the Food and Drug Administration said the agency will soon unveil a new framework detailing what companies must do to seek approval of vaccines, a move that comes as the Trump ...
A coalition of public health organizations, pediatricians and parents has filed a federal lawsuit challenging the Food and Drug Administration's new enforcement policy that allows e-cigarette and ...
The FDA draft guidance recommends MRD and CR as endpoints for accelerated drug approval in multiple myeloma, emphasizing their role in indicating deep treatment response. MRD negativity is defined as ...
The U.S. Sentencing Guidelines play a pivotal role in some of the federal government's most consequential drug policy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results